Edition:
United Kingdom

People: Merrimack Pharmaceuticals Inc (MACK.OQ)

MACK.OQ on NASDAQ Stock Exchange Global Market

5.00USD
18 Jan 2019
Change (% chg)

$0.02 (+0.40%)
Prev Close
$4.98
Open
$5.01
Day's High
$5.03
Day's Low
$4.81
Volume
6,956
Avg. Vol
15,687
52-wk High
$11.70
52-wk Low
$3.35

Franchi, Jean 

Ms. Jean M. Franchi has been appointed as Chief Financial Officer,Principal Financial Officer, Principal Accounting Officer, Treasurer of the company effective August 21, 2017. She previously served as Chief Financial Officer, Treasurer and Secretary at Dimension Therapeutics, Inc., a biotechnology company, from August 2015 to July 2017. From February 2012 to July 2015, Ms. Franchi served as Chief Financial Officer at Good Start Genetics, Inc., a molecular genetics information company. From 1995 to 2011, Ms. Franchi held various positions at Sanofi Genzyme, a global pharmaceutical company, including Senior Vice President of Corporate Finance, Senior Vice President of Business Unit Finance, Vice President of Finance and Controller, Product Line and International Group. Ms. Franchi holds a B.B.A. from Hofstra University and successfully completed the Uniform CPA Examination.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --